Zilganersen
Zilganersen, sold under the brand name Zanvastro, is a medication used for the treatment of Alexander disease.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Zilganersen, sold under the brand name Zanvastro, is a medication used for the treatment of Alexander disease. It is a glial fibrillary acidic protein (GFAP)-directed antisense oligonucleotide. The most common side effects include vomiting, back pain, cough, headache, and post-lumbar puncture syndrome. Zilganersen was approved for medical use in the United States in September 2026.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1378158398 under CC BY-SA 4.0; modifications have been made.